Login
Home
Charts
Search
Watchlist
Products

Anlon Healthcare Ltd

AHCL·NSE
₹28.86+9.98%Tue, 22 Sept '26 15:57
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Anlon Healthcare Ltd

AHCL
NSE
₹28.86
+9.98%
|Tue, 22 Sept '26 15:57
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,534Cr
Close
Close Price
₹28.86
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
48.10
PS
Price To Sales
8.92
Revenue
Revenue
₹172Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2025Jun 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
4933365188
Growth YoY
Revenue Growth YoY%
4.0162.9
Expenses
ExpensesCr
3227233672
Operating Profit
Operating ProfitCr
176121516
OPM
OPM%
35.118.834.530.117.8
Other Income
Other IncomeCr
00000
Interest Expense
Interest ExpenseCr
11211
Depreciation
DepreciationCr
10001
PBT
PBTCr
155111414
Tax
TaxCr
-11535
PAT
PATCr
1745118
Growth YoY
PAT Growth YoY%
-33.5133.2
NPM
NPM%
34.010.714.521.89.5
EPS
EPS₹
5.20.90.10.20.2
QuarterMar 2025Jun 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
4933365188
Growth YoY
Revenue Growth YoY%
4.0162.9
Expenses
ExpensesCr
3227233672
Operating Profit
Operating ProfitCr
176121516
OPM
OPM%
35.118.834.530.117.8
Other Income
Other IncomeCr
00000
Interest Expense
Interest ExpenseCr
11211
Depreciation
DepreciationCr
10001
PBT
PBTCr
155111414
Tax
TaxCr
-11535
PAT
PATCr
1745118
Growth YoY
PAT Growth YoY%
-33.5133.2
NPM
NPM%
34.010.714.521.89.5
EPS
EPS₹
5.20.90.10.20.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026
Revenue
RevenueCr
120172
Growth
Revenue Growth%
43.0
Expenses
ExpensesCr
88124
Operating Profit
Operating ProfitCr
3248
OPM
OPM%
26.827.6
Other Income
Other IncomeCr
00
Interest Expense
Interest ExpenseCr
44
Depreciation
DepreciationCr
22
PBT
PBTCr
2743
Tax
TaxCr
613
PAT
PATCr
2129
Growth
PAT Growth%
41.8
NPM
NPM%
17.116.9
EPS
EPS₹
6.40.6
Financial YearMar 2025Mar 2026
Revenue
RevenueCr
120172
Growth
Revenue Growth%
43.0
Expenses
ExpensesCr
88124
Operating Profit
Operating ProfitCr
3248
OPM
OPM%
26.827.6
Other Income
Other IncomeCr
00
Interest Expense
Interest ExpenseCr
44
Depreciation
DepreciationCr
22
PBT
PBTCr
2743
Tax
TaxCr
613
PAT
PATCr
2129
Growth
PAT Growth%
41.8
NPM
NPM%
17.116.9
EPS
EPS₹
6.40.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
4053
Reserves
ReservesCr
41177
Current Liabilities
Current LiabilitiesCr
60108
Non Current Liabilities
Non Current LiabilitiesCr
4112
Total Liabilities
Total LiabilitiesCr
181374
Current Assets
Current AssetsCr
158308
Non Current Assets
Non Current AssetsCr
2366
Total Assets
Total AssetsCr
181374
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
4053
Reserves
ReservesCr
41177
Current Liabilities
Current LiabilitiesCr
60108
Non Current Liabilities
Non Current LiabilitiesCr
4112
Total Liabilities
Total LiabilitiesCr
181374
Current Assets
Current AssetsCr
158308
Non Current Assets
Non Current AssetsCr
2366
Total Assets
Total AssetsCr
181374

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-22-59
Investing Cash Flow
Investing Cash FlowCr
3-36
Financing Cash Flow
Financing Cash FlowCr
19118
Net Cash Flow
Net Cash FlowCr
023
Free Cash Flow
Free Cash FlowCr
-19-95
CFO To PAT
CFO To PAT%
-106.7-202.5
CFO To EBITDA
CFO To EBITDA%
-68.0-124.0
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-22-59
Investing Cash Flow
Investing Cash FlowCr
3-36
Financing Cash Flow
Financing Cash FlowCr
19118
Net Cash Flow
Net Cash FlowCr
023
Free Cash Flow
Free Cash FlowCr
-19-95
CFO To PAT
CFO To PAT%
-106.7-202.5
CFO To EBITDA
CFO To EBITDA%
-68.0-124.0

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5921,534
Price To Earnings
Price To Earnings
20.848.1
Price To Sales
Price To Sales
3.48.9
Price To Book
Price To Book
2.66.7
EV To EBITDA
EV To EBITDA
13.326.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.034.134.1
OPM
OPM%
26.827.627.6
NPM
NPM%
17.116.916.9
ROCE
ROCE%
20.816.916.9
ROE
ROE%
25.512.612.6
ROA
ROA%
11.37.87.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5921,534
Price To Earnings
Price To Earnings
20.848.1
Price To Sales
Price To Sales
3.48.9
Price To Book
Price To Book
2.66.7
EV To EBITDA
EV To EBITDA
13.326.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.034.134.1
OPM
OPM%
26.827.627.6
NPM
NPM%
17.116.916.9
ROCE
ROCE%
20.816.916.9
ROE
ROE%
25.512.612.6
ROA
ROA%
11.37.87.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Anlon Healthcare Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/1cbshv97hsj3th96j5gjpyq1.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/70ngaynh2fudbidm9xlmchwl.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/qhjpim7dkpdxgoa0h973toxp.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/fhbjveijrot66llswjffmgyu.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/b5lbr3jwwdwnzcgnbiqg1hxy.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/o57na40kvr9bh1g5bg5lwq2x.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/4yiyjn9p6ljxs31kyr9l79j1.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/cmlrx2xyklux60w6thkpbo5r.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/pgru5out2t0m1xa54sxmqh75.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/e6wqdgnwgxzkvzmww7cg16s4.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/6dit273edx7895xpe9onebrt.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/zbq9utb0djyrdhew1zkhl5t9.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/gbe6nofusfk20oigp8o5d3ev.pdf

Concall Transcript Summaries — Anlon Healthcare Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AAHCL/transcript-notes/202606/1cbshv97hsj3th96j5gjpyq1.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AAHCL/transcript-notes/202603/70ngaynh2fudbidm9xlmchwl.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AAHCL/transcript-notes/202512/qhjpim7dkpdxgoa0h973toxp.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AAHCL/transcript-notes/202509/fhbjveijrot66llswjffmgyu.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies